Source: Annual Congress 2006 - Systemic effects of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Baguet, P. Levy, R. Tamisier, H. Pierre, M. Peeters, S. Mouret, J. M. Mallion, J. L. Pepin (Grenoble, France). Masked hypertension and obstructive sleep apnea syndrome (OSAS). Eur Respir J 2006; 28: Suppl. 50, 2439

Member's Comments

No comment yet.

Related content which might interest you: Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Hypertension and obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Prevalence of glaucoma in obstructive sleep apnea syndrome Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 Resistant arterial hypertension and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Screening for obstructive sleep apnea (OSA) in acromegaly Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 The frequency of rhinitis in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008 Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new? Year: 2020 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002